Akso Health Group
AHG
$1.35
$0.00290.22%
| 03/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 70.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 70.19% | |||
| Cost of Revenue | 0.00% | 68.16% | |||
| Gross Profit | 0.00% | 114.95% | |||
| SG&A Expenses | 0.00% | 172.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 144.38% | |||
| Operating Income | 0.00% | -173.00% | |||
| Income Before Tax | 0.00% | -99.21% | |||
| Income Tax Expenses | 0.00% | -99.19% | |||
| Earnings from Continuing Operations | 0.00% | -97.58% | |||
| Earnings from Discontinued Operations | 0.00% | 98.37% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 9,833.33% | |||
| Net Income | 0.00% | -73.57% | |||
| EBIT | 0.00% | -173.00% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | 44.44% | |||
| Normalized Basic EPS | 0.00% | 37.11% | |||
| EPS Diluted | 0.00% | 36.38% | |||
| Normalized Diluted EPS | 0.00% | 37.11% | |||
| Average Basic Shares Outstanding | 0.00% | 212.60% | |||
| Average Diluted Shares Outstanding | 0.00% | 212.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
